Twist Bioscience to Present at Upcoming Investor Conferences

Rhea-AI Summary

Twist Bioscience (NASDAQ: TWST), a core mid-cap growth and value equity company in the life sciences segment of the health care sector, has announced its executives' participation in upcoming investor conferences.

The schedule includes:

• Emily Leproust, Ph.D., CEO and co-founder, and Adam Laponis, CFO, at the TD Cowen 45th Annual Health Care Conference on March 4 in Boston (fireside chat at 1:50 pm ET)
• Patrick Finn, Ph.D., president and COO, and Adam Laponis, CFO, at the Leerink Global Biopharma Conference 2025 on March 11 in Miami (fireside chat at 9:20 am ET)
• Patrick Finn and Adam Laponis at the Barclays Global Healthcare Conference 2025 on March 12 in Miami (fireside chat at 8:30 am ET)

All fireside chats will be webcast live through the investor relations section of the company's website and archived for 30 days after the events.

Positive

• Twist Bioscience is actively engaging with investors through participation in multiple high-profile healthcare conferences
• The company is providing transparent access to executive presentations through live webcasts and archived recordings
• Senior leadership including the CEO, CFO, and COO are directly representing the company to investors

Negative

• The press release doesn't provide any information about the company's financial performance or business updates
• No specific topics or strategic announcements are mentioned for the upcoming conference presentations
• The press release lacks details about the company's recent achievements or future outlook

SOUTH SAN FRANCISCO, Calif.--(BUSINESS WIRE)-- Twist Bioscience Corporation (NASDAQ: TWST), a core mid-cap growth and value equity company in the life sciences segment of the health care sector, today announced that its executives will participate in fireside chats at the following upcoming investor conferences:

• Emily Leproust, Ph.D., CEO and co-founder, and Adam Laponis, CFO, will participate in a fireside chat at the TD Cowen 45th Annual Health Care Conference on Tuesday, March 4 in Boston, MA; fireside chat at 1:50 pm Eastern Time
• Patrick Finn, Ph.D., president and COO, and Adam Laponis, CFO, will participate in a fireside chat at the Leerink Global Biopharma Conference 2025 on Tuesday, March 11 in Miami, FL; fireside chat at 9:20 am Eastern Time
• Patrick Finn, Ph.D., president and COO, and Adam Laponis, CFO, will participate in a fireside chat at the Barclays Global Healthcare Conference 2025 on Wednesday, March 12 in Miami, FL; fireside chat at 8:30 am Eastern Time

The fireside chats will be webcast live and can be accessed by visiting the “Investor Calendar” page of the investor relations section of the company's website here. A replay of the fireside chats will be archived for a period of 30 days following the conclusion of the live events.

About Twist Bioscience Corporation

Twist Bioscience is a leading and rapidly growing synthetic biology and genomics company that has developed a disruptive DNA synthesis platform to industrialize the engineering of biology. The core of the platform is a proprietary technology that pioneers a new method of manufacturing synthetic DNA by “writing” DNA on a silicon chip. Twist is leveraging its unique technology to manufacture a broad range of synthetic DNA-based products, including synthetic genes, tools for next-generation sequencing (NGS) preparation, and antibody libraries for drug discovery and development. Twist is also pursuing longer-term opportunities in digital data storage in DNA and biologics drug discovery. Twist makes products for use across many industries including healthcare, industrial chemicals, agriculture and academic research.

Follow us on LinkedIn | X | YouTube | Instagram | Bluesky

View source version on businesswire.com: https://www.businesswire.com/news/home/20250225728311/en/

For Investors:

Angela Bitting

SVP, Corporate Affairs

925-202-6211

abitting@twistbioscience.com

For Media:

Amanda Houlihan

Communications Manager

774-265-5334

ahoulihan@twistbioscience.com

Source: Twist Bioscience Corporation

FAQ

Which investor conferences will Twist Bioscience (TWST) executives attend in March 2025?

Twist Bioscience executives will attend three investor conferences in March 2025: TD Cowen 45th Annual Health Care Conference in Boston on March 4, Leerink Global Biopharma Conference in Miami on March 11, and Barclays Global Healthcare Conference in Miami on March 12.

Who will represent Twist Bioscience (TWST) at the TD Cowen Health Care Conference?

Emily Leproust, Ph.D., CEO and co-founder, and Adam Laponis, CFO, will represent Twist Bioscience at the TD Cowen 45th Annual Health Care Conference on March 4 in Boston.

How can investors access Twist Bioscience's (TWST) fireside chats at the upcoming conferences?

Investors can access the fireside chats via live webcast by visiting the "Investor Calendar" page in the investor relations section of Twist Bioscience's website. Replays will be archived for 30 days following each event.

What time is Twist Bioscience's (TWST) presentation at the Barclays Global Healthcare Conference 2025?

Twist Bioscience's fireside chat at the Barclays Global Healthcare Conference 2025 is scheduled for 8:30 am Eastern Time on Wednesday, March 12 in Miami, FL.

Which Twist Bioscience (TWST) executives will participate in the most investor conferences in March 2025?

Adam Laponis, CFO of Twist Bioscience, will participate in all three investor conferences in March 2025, while Patrick Finn, Ph.D., president and COO, will attend two conferences (Leerink and Barclays).